These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 74245)

  • 1. Enhancement of antiviral protection against encephalomyocarditis virus by a combination of isoprinosine and interferon.
    Chany C; Cerutti I
    Arch Virol; 1977; 55(3):225-31. PubMed ID: 74245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Stimulation by isoprinosine of the antiviral effect of interferon].
    Chany C; Cerutti I
    C R Acad Hebd Seances Acad Sci D; 1977 Feb; 284(6):499-501. PubMed ID: 66996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoprinosine increases the antitumor action of interferon.
    Cerutti I; Chany C; Schlumberger JF
    Cancer Treat Rep; 1978 Nov; 62(11):1971-4. PubMed ID: 83190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined use of isoprinosine and an interferon inducer in experimental viral infection].
    Fomina AN; Grigorian SS; Nikolaeva OV; Ershov FI
    Antibiotiki; 1980 Nov; 25(11):854-7. PubMed ID: 6160806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoprinosine increases the antitumor action of interferon.
    Cerutti I; Chany C; Schlumberger JF
    Int J Immunopharmacol; 1979; 1(1):59-63. PubMed ID: 95187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory activity of isoprinosine on experimental viral infections in avian models.
    Moya P; Alonso ML; Baixeras E; Ronda E
    Int J Immunopharmacol; 1984; 6(4):339-43. PubMed ID: 6207123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of different mouse interferons in mice infected with encephalomyocarditis (EMC).
    Lobodzińska M; Albin M
    Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):49-55. PubMed ID: 6184029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ammonium 5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infections in mice.
    Werner GH; Jasmin C; Chermann JC
    J Gen Virol; 1976 Apr; 31(1):59-64. PubMed ID: 177729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation by levamisole, methisoprinol, and adenine or adenosine of the inhibitory activity of human interferon against encephalomyocarditis virus.
    Muñoz A; García RA; Pérez-Aranda A
    Antimicrob Agents Chemother; 1986 Jul; 30(1):192-5. PubMed ID: 2428301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of interferon, antibodies and macrophages in the protective effect of Corynebacterium parvum on encephalomyocarditis virus-induced disease in mice.
    Géniteau-Legendre M; Forestier F; Quéro AM; German A
    Antiviral Res; 1987 Mar; 7(3):161-7. PubMed ID: 2440381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-viral activity of single-stranded homopolynucleotides against encephalomyocarditis virus and Semliki Forest virus in adult mice without interferon induction.
    Stebbing N; Grantham CA; Carey NH
    J Gen Virol; 1976 Jan; 30(1):21-39. PubMed ID: 173799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of mice against encephalomyocarditis virus infection by preparations of transfer RNA.
    Stebbing N; Grantham CA; Kaminski F; Lindley IJ
    J Gen Virol; 1977 Jan; 34(1):73-85. PubMed ID: 188982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of recurrent herpes simplex virus infection using interferon and isoprinosine].
    Vujosević M; Nikolić S; Bujko M; Zerjav S; Keserović N
    Srp Arh Celok Lek; 1988 Oct; 116(10):875-85. PubMed ID: 2469129
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigation of the anti-viral mechanism of poly I and poly C against encephalomyocarditis virus infection in the absence of interferon induction in mice.
    Stebbing N; Grantham CA; Kaminski F
    J Gen Virol; 1976 Jul; 32(1):25-35. PubMed ID: 182913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis and therapy of virulent encephalomyocarditis virus infection in mice by monoclonal antibodies. Brief report.
    Vlaspolder F; Kraaijeveld CA; van Buuren R; Harmsen M; Benaissa-Trouw BJ; Snippe H
    Arch Virol; 1988; 98(1-2):123-30. PubMed ID: 2829795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: a controlled study.
    Haddad FS; Risk WS
    Ann Neurol; 1980 Feb; 7(2):185-8. PubMed ID: 6154441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced resistance against encephalomyocarditis virus infection in mice, induced by a nonviable Mycobacterium tuberculosis oil-droplet vaccine.
    Lodmell DL; Ewalt LC
    Infect Immun; 1978 Jan; 19(1):225-30. PubMed ID: 203533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of murine interferon by a substituted pyrimidine.
    Nichol FR; Weed SD; Underwood GE
    Antimicrob Agents Chemother; 1976 Mar; 9(3):433-9. PubMed ID: 176934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-viral effects of single-stranded polynucleotides against avirulent Semliki Forest virus infection of mice and avirulent infection of rats with encephalomyocarditis virus.
    Stebbing N; Lindley IJ
    Arch Virol; 1980; 64(1):57-66. PubMed ID: 6246856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of sex and early interferon production in the susceptibility of mice to encephalomyocarditis virus.
    Pozzetto B; Gresser I
    J Gen Virol; 1985 Apr; 66 ( Pt 4)():701-9. PubMed ID: 2580047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.